# Bacillus Coagulans Based Product in IBS-Diarrhea

> **NCT07520422** · NA · COMPLETED · sponsor: **Bioagile Therapeutics Pvt. Ltd.** · enrollment: 50 (actual)

## Conditions studied

- IBS-D (Diarrhea-predominant)

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotic Arm
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07520422
- **Lead sponsor:** Bioagile Therapeutics Pvt. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-25
- **Primary completion:** 2023-05-25
- **Final completion:** 2023-05-25
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2026-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07520422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07520422, "Bacillus Coagulans Based Product in IBS-Diarrhea". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07520422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*